Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Interindividual variability in the effect of statin exposure on the tissue transcriptome
FY 2012-13
Summary
Variability in drug response between individuals is an important challenge for clinicians, because it is difficult to predict who will respond well to a medication, and who might have an adverse reaction.
One way that drugs affect the body is by changing the amount or rate at which genes are expressed thereby altering the production of proteins and non-coding RNAs. Genetic diversity can further lead to differences in gene expression between individuals, and the complex interplay between drugs, genetic variation, and gene expression is not well understood.
Statins are a type of medication commonly prescribed to decrease low-density lipoprotein (LDL) cholesterol, and reduce cardiovascular disease risk. Up to 10% of individuals who take a statin will experience muscle pain or weakness. In very rare cases, a life threatening form of muscle damage may occur. To be effective, statins must enter the liver, where the majority of cholesterol synthesis occurs. There is also evidence to suggest that statins work in other tissues, through inflammation-related pathways, to reduce overall cardiovascular disease risk.
This project seeks to identify the effects of statin use on gene expression in multiple tissues in the body, including liver and muscle, and the role of genetic variation in this expression. By combining information about gene expression with information about an individual's DNA, we aim to identify genetic variants that contribute to variability in statin response.
This project will result in an enhanced understanding of how statin exert their effect over multiple tissues. This will improve our knowledge of the specificity and biochemical impact of this treatment. In addition, new insight to the role of genetic variation on changes to gene expression following statin exposure will improve our ability to monitor and predict which individuals might suffer from adverse side effects or benefit from their use.
Department
Program
Banting Postdoctoral Fellowship Program
Recipient
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
273389
Name
De Gorter Marianne K
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Interindividual variability in the effect of statin exposure on the tissue transcriptome
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Cardiovascular Disease; Expression Quantitative Trait Loci (Eqtls); Gene Expression; Gene Regulation; Pharmacogenomics; Rna Sequencing; Statins; Tissue Transcriptomics
Abstract
Variability in drug response between individuals is an important challenge for clinicians, because it is difficult to predict who will respond well to a medication, and who might have an adverse reaction.
One way that drugs affect the body is by changing the amount or rate at which genes are expressed thereby altering the production of proteins and non-coding RNAs. Genetic diversity can further lead to differences in gene expression between individuals, and the complex interplay between drugs, genetic variation, and gene expression is not well understood.
Statins are a type of medication commonly prescribed to decrease low-density lipoprotein (LDL) cholesterol, and reduce cardiovascular disease risk. Up to 10% of individuals who take a statin will experience muscle pain or weakness. In very rare cases, a life threatening form of muscle damage may occur. To be effective, statins must enter the liver, where the majority of cholesterol synthesis occurs. There is also evidence to suggest that statins work in other tissues, through inflammation-related pathways, to reduce overall cardiovascular disease risk.
This project seeks to identify the effects of statin use on gene expression in multiple tissues in the body, including liver and muscle, and the role of genetic variation in this expression. By combining information about gene expression with information about an individual's DNA, we aim to identify genetic variants that contribute to variability in statin response.
This project will result in an enhanced understanding of how statin exert their effect over multiple tissues. This will improve our knowledge of the specificity and biochemical impact of this treatment. In addition, new insight to the role of genetic variation on changes to gene expression following statin exposure will improve our ability to monitor and predict which individuals might suffer from adverse side effects or benefit from their use.
Competitiondate
201211
Approvedterm2
2 yrs 0 mth
Pinamesdelim
De Gorter, Marianne K
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~